Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 31 Mar 2025

Increased TIGIT expression correlates with impaired NK cell function in diffuse large B-cell lymphoma

in Hematologic Malignancies

Hui Lu
Xiaoyan Zhao
Liqiong Liu
Lu Zhang
Huafang Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1551061

722 views

Original Research

Published on 31 Mar 2025

The association of FAT1 mutations with therapeutic outcomes in AML, especially in receiving venetoclax combination

in Hematologic Malignancies

Tao Wang
Junxia Huang
Yongqian Jia
Junting Li
Weiwei Mou
Guang Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1456832

493 views

Editorial

Published on 27 Mar 2025

Editorial: Elderly patients and lymphoma

in Hematologic Malignancies

Maria S. Infante
José-Angel Hernández-Rivas

Frontiers in Oncology

doi 10.3389/fonc.2025.1568846

356 views

Case Report

Published on 27 Mar 2025

Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement

in Hematologic Malignancies

Andrius Žučenka
Milvydė Tamutytė

Frontiers in Oncology

doi 10.3389/fonc.2025.1530852

900 views

Original Research

Accepted on 26 Mar 2025

TP53 mutation and immunohistochemical p53 expression characteristics in diffuse large B-cell lymphoma

in Hematologic Malignancies

Yiping Jin
YI Wang
Lu Wang
He Zhang
Beibei Ren
Jiawen Zheng
Qingxin Xia
Yanyan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1550207

Case Report

Published on 25 Mar 2025

Endoscopic ultrasound-guided fine-needle aspiration in diagnosing primary medistinal large B-cell lymphoma: a case report

in Hematologic Malignancies

Jingyan Tang
Yuchen Guan
Jianfeng Zhang
Chengqi Guan

Frontiers in Oncology

doi 10.3389/fonc.2025.1404211

342 views

Brief Research Report

Published on 25 Mar 2025

Identification of a novel NRF1::PDGFRA fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions

in Hematologic Malignancies

Jialong Liu
Yaqing Feng
Yanfang Zhang
Yingnan Xiao
Xi Liu
Tingting Xiao
Junyan Zou
Kai Fan
Lisha Lu
Xiaoxia Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1552928

474 views

Original Research

Accepted on 24 Mar 2025

IMPACT OF PRIMARY CANCER HISTORY AND MOLECULAR LANDSCAPE IN THERAPY-RELATED MYELOID NEOPLASMS

in Hematologic Malignancies

Alessandro Costa
Federica Pilo
Martina Pettinau
Eugenia Piras
Clara Targhetta
Rodrigo Rojas
Paola Deias
Olga Mulas
Giovanni Caocci

Frontiers in Oncology

doi 10.3389/fonc.2025.1563990

125 views

Mini Review

Published on 21 Mar 2025

The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia

in Hematologic Malignancies

Grigorios Alvanidis
Dimitrios Kotsos
Christina Frouzaki
Amalia Fola
Evdoxia Hatjiharissi

Frontiers in Oncology

doi 10.3389/fonc.2025.1549891

1,238 views

Original Research

Published on 21 Mar 2025

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis

in Hematologic Malignancies

Shujing Guo
Jile Liu
Bing Wang
Xiaomei Zhang
Yifan Zhao
Jianmei Xu
Xinping Cao
Mohan Zhao
Xia Xiao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1549809

523 views

Correction

Published on 21 Mar 2025

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

Si Yu Lin
Ke Jie Lu
Xiao Na Zheng
Jian Hou
Ting Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1559194

337 views

Original Research

Published on 20 Mar 2025

Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma

in Hematologic Malignancies

Fujue Wang
Yu Gao
Yue Chen
Pian Li
Yao Zeng
Yingying Chen
Yangcui Yin
Yongqian Jia
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1542829

604 views

Editorial

Published on 19 Mar 2025

Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective

in Hematologic Malignancies

Salvatore Leotta
Sabrina Giammarco
Jacopo Mariotti

Frontiers in Oncology

doi 10.3389/fonc.2025.1582751

281 views

Systematic Review

Published on 18 Mar 2025

Prognostic and clinicopathological value of the controlling nutritional status score in patients with multiple myeloma: a meta-analysis

in Hematologic Malignancies

Yin Jin
Wenfei Gu

Frontiers in Oncology

doi 10.3389/fonc.2025.1517223

487 views

Case Report

Published on 14 Mar 2025

Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report

in Hematologic Malignancies

Tejasvini Vaid
Thomas S. Gunning
Rachel Cohen
Alexandra Della Pia
Jason Voss
Melinda Weber
Andrew L. Pecora
Lori A. Leslie
Tatyana Feldman
Andre H. Goy

Frontiers in Oncology

doi 10.3389/fonc.2025.1502782

959 views

Original Research

Published on 13 Mar 2025

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment

in Hematologic Malignancies

Vanessa Cristaldi
Lodovico Terzi di Bergamo
Lucrezia Patruno
Marinos Kallikourdis
Giada Andrea Cassanmagnago
Francesco Corrado
Eleonora Calabretta
Adalgisa Condoluci
Martina di Trani
Daoud Rahal

Frontiers in Oncology

doi 10.3389/fonc.2025.1518107

730 views